• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Highly potent activity of isopulegol-derived substituted octahydro-2H-chromen-4-ols against influenza A and B viruses

tetano

Editor, Senior Moderator
Bioorg Med Chem Lett. 2018 Apr 24. pii: S0960-894X(18)30369-X. doi: 10.1016/j.bmcl.2018.04.057. [Epub ahead of print]
[h=1]Highly potent activity of isopulegol-derived substituted octahydro-2H-chromen-4-ols against influenza A and B viruses.[/h] Ilyina IV[SUP]1[/SUP], Zarubaev VV[SUP]2[/SUP], Lavrentieva IN[SUP]2[/SUP], Shtro AA[SUP]3[/SUP], Esaulkova IL[SUP]4[/SUP], Korchagina DV[SUP]5[/SUP], Borisevich SS[SUP]6[/SUP], Volcho KP[SUP]7[/SUP], Salakhutdinov NF[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] A set of (-)-isopulegol derived octahydro-2H-chromen-4-ols was synthesized and evaluated in vitro for antiviral activity against panel of reference influenza virus strains differing in subtype, origin (human or avian) and drug resistance. Compound (4R)-11a produced via one-pot synthesis by interaction between (-)-isopulegol and acetone was found to exhibit an outstanding activity against a number of H1N1 and H2N2 influenza virus strains with selectivity index more than 1500. (4R)-11a was shown to be most potent at early stages of viral cycle. Good correlation between anti-viral activity and calculated binding energy to hemagglutinin TBHQ active site was demonstrated.


[h=4]KEYWORDS:[/h] Antiviral; Chromene; Influenza; Monoterpene; Montmorillonite K10

PMID: 29716780 DOI: 10.1016/j.bmcl.2018.04.057
 
Back
Top Bottom